IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q2 2022 Holdings

Filed 2022-08-15 | 11 holdings | $237.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biora Inc.Note 7.250% 12/074319FAB3$65.5K$103,500,00027.6%
Amryt Pharma PLCSponsored ADS03217L106$61.9K8,857,26826.0%
Biora Inc.COM74319F107$20.9K29,855,8478.8%
Omeros CorpNOTE 5.250% 2/1682143AG7$20.3K$35,150,0008.5%
Omeros CorpNOTE 6.250%11/1682143AE2$18.6K$21,005,0007.8%
Caremax IncCOM CL A14171W103$16.3K4,487,2196.9%
RVL Pharmaceuticals PLCSHSG6S41R101$11.1K8,148,8324.7%
BridgeBio Pharma Inc.NOTE 2.250% 2/010806XAD4$8.4K$20,000,0003.5%
Paratek Pharmaceuticals Inc.NOTE 4.750% 5/0699374AB0$7.9K9,000,0003.3%
Puma Biotechnology Inc(PBYI)COM74587V107$5.1K1,792,1142.1%
Societal Cdmo Inc.Com75629F109$1.8K2,202,4200.7%